ID   ANGT_RAT                Reviewed;         477 AA.
AC   P01015;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   21-JUL-1986, sequence version 1.
DT   02-OCT-2024, entry version 187.
DE   RecName: Full=Angiotensinogen;
DE   AltName: Full=Serpin A8;
DE   Contains:
DE     RecName: Full=Angiotensin-1;
DE     AltName: Full=Angiotensin 1-10;
DE     AltName: Full=Angiotensin I;
DE              Short=Ang I;
DE   Contains:
DE     RecName: Full=Angiotensin-2;
DE     AltName: Full=Angiotensin 1-8;
DE     AltName: Full=Angiotensin II;
DE              Short=Ang II;
DE   Contains:
DE     RecName: Full=Angiotensin-3;
DE     AltName: Full=Angiotensin 2-8;
DE     AltName: Full=Angiotensin III;
DE              Short=Ang III;
DE     AltName: Full=Des-Asp[1]-angiotensin II;
DE   Contains:
DE     RecName: Full=Angiotensin-4;
DE     AltName: Full=Angiotensin 3-8;
DE     AltName: Full=Angiotensin IV;
DE              Short=Ang IV;
DE   Contains:
DE     RecName: Full=Angiotensin 1-9;
DE   Contains:
DE     RecName: Full=Angiotensin 1-7;
DE   Contains:
DE     RecName: Full=Angiotensin 1-5;
DE   Contains:
DE     RecName: Full=Angiotensin 1-4;
DE   Flags: Precursor;
GN   Name=Agt; Synonyms=Serpina8;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Wistar;
RX   PubMed=6572971; DOI=10.1073/pnas.80.8.2196;
RA   Ohkubo H., Kageyama R., Ujihara M., Hirose T., Inayama S., Nakanishi S.;
RT   "Cloning and sequence analysis of cDNA for rat angiotensinogen.";
RL   Proc. Natl. Acad. Sci. U.S.A. 80:2196-2200(1983).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=6330095; DOI=10.1016/s0021-9258(17)39689-8;
RA   Tanaka T., Ohkubo H., Nakanishi S.;
RT   "Common structural organization of the angiotensinogen and the alpha 1-
RT   antitrypsin genes.";
RL   J. Biol. Chem. 259:8063-8065(1984).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, and Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PROTEIN SEQUENCE OF 25-34.
RX   PubMed=4344907; DOI=10.1248/cpb.20.1579;
RA   Nakayama T., Nakajima T., Sokabe H.;
RT   "Comparative studies on angiotensins. II. Structure of rat angiotensin and
RT   its identification by DNS-method.";
RL   Chem. Pharm. Bull. 20:1579-1581(1972).
RN   [5]
RP   FUNCTION.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=9508787; DOI=10.1007/bf03401733;
RA   Ruiz-Opazo N., Hirayama K., Akimoto K., Herrera V.L.;
RT   "Molecular characterization of a dual endothelin-1/Angiotensin II
RT   receptor.";
RL   Mol. Med. 4:96-108(1998).
RN   [6]
RP   FUNCTION OF ANGIOTENSIN 1-7.
RX   PubMed=18026570; DOI=10.2119/2007-00073.fraga-silva;
RA   Fraga-Silva R.A., Pinheiro S.V.B., Goncalves A.C., Alenina N., Bader M.,
RA   Santos R.A.S.;
RT   "The antithrombotic effect of angiotensin-(1-7) involves mas-mediated NO
RT   release from platelets.";
RL   Mol. Med. 14:28-35(2008).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 25-477, AND DISULFIDE BOND.
RX   PubMed=20927107; DOI=10.1038/nature09505;
RA   Zhou A., Carrell R.W., Murphy M.P., Wei Z., Yan Y., Stanley P.L.,
RA   Stein P.E., Broughton Pipkin F., Read R.J.;
RT   "A redox switch in angiotensinogen modulates angiotensin release.";
RL   Nature 468:108-111(2010).
CC   -!- FUNCTION: Essential component of the renin-angiotensin system (RAS), a
CC       potent regulator of blood pressure, body fluid and electrolyte
CC       homeostasis. {ECO:0000250|UniProtKB:P01019}.
CC   -!- FUNCTION: [Angiotensin-2]: Acts directly on vascular smooth muscle as a
CC       potent vasoconstrictor, affects cardiac contractility and heart rate
CC       through its action on the sympathetic nervous system, and alters renal
CC       sodium and water absorption through its ability to stimulate the zona
CC       glomerulosa cells of the adrenal cortex to synthesize and secrete
CC       aldosterone. Acts by binding to angiotensin receptors AGTR1 and AGTR2
CC       (By similarity). Also binds the DEAR/FBXW7-AS1 receptor
CC       (PubMed:9508787). {ECO:0000250|UniProtKB:P01019,
CC       ECO:0000269|PubMed:9508787}.
CC   -!- FUNCTION: [Angiotensin-3]: Stimulates aldosterone release.
CC       {ECO:0000250|UniProtKB:P01019}.
CC   -!- FUNCTION: [Angiotensin 1-7]: Is a ligand for the G-protein coupled
CC       receptor MAS1 (By similarity). Has vasodilator and antidiuretic effects
CC       (By similarity). Has an antithrombotic effect that involves MAS1-
CC       mediated release of nitric oxide from platelets (PubMed:18026570).
CC       {ECO:0000250|UniProtKB:P11859, ECO:0000269|PubMed:18026570}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000305|PubMed:4344907}.
CC   -!- PTM: In response to low blood pressure, the enzyme renin/REN cleaves
CC       angiotensinogen to produce angiotensin-1. Angiotensin-1 is a substrate
CC       of ACE (angiotensin converting enzyme) that removes a dipeptide to
CC       yield the physiologically active peptide angiotensin-2. Angiotensin-1
CC       and angiotensin-2 can be further processed to generate angiotensin-3,
CC       angiotensin-4. Angiotensin 1-9 is cleaved from angiotensin-1 by ACE2
CC       and can be further processed by ACE to produce angiotensin 1-7,
CC       angiotensin 1-5 and angiotensin 1-4. Angiotensin 1-7 has also been
CC       proposed to be cleaved from angiotensin-2 by ACE2 or from angiotensin-1
CC       by MME (neprilysin) (By similarity). {ECO:0000250|UniProtKB:P01019}.
CC   -!- PTM: The disulfide bond is labile. Angiotensinogen is present in the
CC       circulation in a near 40:60 ratio with the oxidized disulfide-bonded
CC       form, which preferentially interacts with receptor-bound renin.
CC       {ECO:0000269|PubMed:20927107}.
CC   -!- SIMILARITY: Belongs to the serpin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L00094; AAA98779.1; -; Genomic_DNA.
DR   EMBL; L00091; AAA98779.1; JOINED; Genomic_DNA.
DR   EMBL; L00092; AAA98779.1; JOINED; Genomic_DNA.
DR   EMBL; L00093; AAA98779.1; JOINED; Genomic_DNA.
DR   EMBL; BC078741; AAH78741.1; -; mRNA.
DR   EMBL; BC087679; AAH87679.1; -; mRNA.
DR   PIR; A93945; ANRT.
DR   RefSeq; NP_602308.1; NM_134432.2.
DR   RefSeq; XP_008770819.1; XM_008772597.2.
DR   PDB; 1SMR; X-ray; 2.00 A; B/D/F/H=30-33.
DR   PDB; 2WXZ; X-ray; 2.80 A; A/C=25-477.
DR   PDB; 2WY1; X-ray; 3.15 A; A/B=25-477.
DR   PDBsum; 1SMR; -.
DR   PDBsum; 2WXZ; -.
DR   PDBsum; 2WY1; -.
DR   AlphaFoldDB; P01015; -.
DR   SMR; P01015; -.
DR   BioGRID; 246369; 1.
DR   STRING; 10116.ENSRNOP00000024917; -.
DR   BindingDB; P01015; -.
DR   ChEMBL; CHEMBL5291508; -.
DR   MEROPS; I04.953; -.
DR   GlyCosmos; P01015; 2 sites, No reported glycans.
DR   GlyGen; P01015; 2 sites.
DR   iPTMnet; P01015; -.
DR   PhosphoSitePlus; P01015; -.
DR   SwissPalm; P01015; -.
DR   PaxDb; 10116-ENSRNOP00000024917; -.
DR   GeneID; 24179; -.
DR   KEGG; rno:24179; -.
DR   UCSC; RGD:2069; rat.
DR   AGR; RGD:2069; -.
DR   CTD; 183; -.
DR   RGD; 2069; Agt.
DR   VEuPathDB; HostDB:ENSRNOG00000018445; -.
DR   eggNOG; KOG2392; Eukaryota.
DR   HOGENOM; CLU_045267_1_0_1; -.
DR   InParanoid; P01015; -.
DR   OrthoDB; 5355105at2759; -.
DR   PhylomeDB; P01015; -.
DR   TreeFam; TF343201; -.
DR   Reactome; R-RNO-2022377; Metabolism of Angiotensinogen to Angiotensins.
DR   Reactome; R-RNO-375276; Peptide ligand-binding receptors.
DR   Reactome; R-RNO-416476; G alpha (q) signalling events.
DR   Reactome; R-RNO-418594; G alpha (i) signalling events.
DR   EvolutionaryTrace; P01015; -.
DR   PRO; PR:P01015; -.
DR   Proteomes; UP000002494; Chromosome 19.
DR   Bgee; ENSRNOG00000018445; Expressed in liver and 19 other cell types or tissues.
DR   GO; GO:0005615; C:extracellular space; IDA:BHF-UCL.
DR   GO; GO:0005179; F:hormone activity; IDA:BHF-UCL.
DR   GO; GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:InterPro.
DR   GO; GO:0031702; F:type 1 angiotensin receptor binding; ISO:RGD.
DR   GO; GO:0031703; F:type 2 angiotensin receptor binding; ISO:RGD.
DR   GO; GO:0035932; P:aldosterone secretion; ISO:RGD.
DR   GO; GO:0038166; P:angiotensin-activated signaling pathway; ISO:RGD.
DR   GO; GO:0003051; P:angiotensin-mediated drinking behavior; IDA:RGD.
DR   GO; GO:0001998; P:angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure; ISO:RGD.
DR   GO; GO:0014824; P:artery smooth muscle contraction; IDA:RGD.
DR   GO; GO:0008306; P:associative learning; IDA:RGD.
DR   GO; GO:0048143; P:astrocyte activation; ISO:RGD.
DR   GO; GO:0001568; P:blood vessel development; ISO:RGD.
DR   GO; GO:0002035; P:brain renin-angiotensin system; ISO:RGD.
DR   GO; GO:0001658; P:branching involved in ureteric bud morphogenesis; ISO:RGD.
DR   GO; GO:0061049; P:cell growth involved in cardiac muscle cell development; IDA:RGD.
DR   GO; GO:0008283; P:cell population proliferation; ISO:RGD.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; IDA:RGD.
DR   GO; GO:0007160; P:cell-matrix adhesion; ISO:RGD.
DR   GO; GO:1904385; P:cellular response to angiotensin; IEP:RGD.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; IEP:RGD.
DR   GO; GO:0042756; P:drinking behavior; ISO:RGD.
DR   GO; GO:0070371; P:ERK1 and ERK2 cascade; IDA:RGD.
DR   GO; GO:0008065; P:establishment of blood-nerve barrier; ISO:RGD.
DR   GO; GO:0030198; P:extracellular matrix organization; ISO:RGD.
DR   GO; GO:0007565; P:female pregnancy; IEP:RGD.
DR   GO; GO:0048144; P:fibroblast proliferation; IDA:RGD.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; IMP:RGD.
DR   GO; GO:0042445; P:hormone metabolic process; ISO:RGD.
DR   GO; GO:0006883; P:intracellular sodium ion homeostasis; IMP:RGD.
DR   GO; GO:0001822; P:kidney development; ISO:RGD.
DR   GO; GO:0002034; P:maintenance of blood vessel diameter homeostasis by renin-angiotensin; ISO:RGD.
DR   GO; GO:0000165; P:MAPK cascade; ISO:RGD.
DR   GO; GO:0016525; P:negative regulation of angiogenesis; IDA:RGD.
DR   GO; GO:0030308; P:negative regulation of cell growth; IMP:RGD.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; ISO:RGD.
DR   GO; GO:0051387; P:negative regulation of neurotrophin TRK receptor signaling pathway; ISO:RGD.
DR   GO; GO:0048662; P:negative regulation of smooth muscle cell proliferation; ISO:RGD.
DR   GO; GO:0034104; P:negative regulation of tissue remodeling; IDA:RGD.
DR   GO; GO:1904706; P:negative regulation of vascular associated smooth muscle cell proliferation; ISO:RGD.
DR   GO; GO:0051402; P:neuron apoptotic process; ISO:RGD.
DR   GO; GO:0035106; P:operant conditioning; IDA:RGD.
DR   GO; GO:0035265; P:organ growth; ISO:RGD.
DR   GO; GO:0001543; P:ovarian follicle rupture; ISO:RGD.
DR   GO; GO:0030432; P:peristalsis; ISO:RGD.
DR   GO; GO:0045777; P:positive regulation of blood pressure; IDA:RGD.
DR   GO; GO:0090190; P:positive regulation of branching involved in ureteric bud morphogenesis; ISO:RGD.
DR   GO; GO:0043123; P:positive regulation of canonical NF-kappaB signal transduction; ISO:RGD.
DR   GO; GO:0010666; P:positive regulation of cardiac muscle cell apoptotic process; IDA:RGD.
DR   GO; GO:0010613; P:positive regulation of cardiac muscle hypertrophy; IDA:BHF-UCL.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IDA:RGD.
DR   GO; GO:0001819; P:positive regulation of cytokine production; ISO:RGD.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IDA:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0010595; P:positive regulation of endothelial cell migration; ISO:RGD.
DR   GO; GO:0045742; P:positive regulation of epidermal growth factor receptor signaling pathway; ISO:RGD.
DR   GO; GO:0010718; P:positive regulation of epithelial to mesenchymal transition; ISS:UniProtKB.
DR   GO; GO:1901203; P:positive regulation of extracellular matrix assembly; ISO:RGD.
DR   GO; GO:0003331; P:positive regulation of extracellular matrix constituent secretion; IDA:RGD.
DR   GO; GO:2001238; P:positive regulation of extrinsic apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0045723; P:positive regulation of fatty acid biosynthetic process; ISO:RGD.
DR   GO; GO:0048146; P:positive regulation of fibroblast proliferation; IDA:BHF-UCL.
DR   GO; GO:1903598; P:positive regulation of gap junction assembly; ISO:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:0046628; P:positive regulation of insulin receptor signaling pathway; IDA:RGD.
DR   GO; GO:1905589; P:positive regulation of L-arginine import across plasma membrane; IDA:RGD.
DR   GO; GO:1905010; P:positive regulation of L-lysine import across plasma membrane; IDA:RGD.
DR   GO; GO:0010744; P:positive regulation of macrophage derived foam cell differentiation; ISO:RGD.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; ISO:RGD.
DR   GO; GO:1902895; P:positive regulation of miRNA transcription; ISO:RGD.
DR   GO; GO:0040018; P:positive regulation of multicellular organism growth; ISO:RGD.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IMP:RGD.
DR   GO; GO:0045429; P:positive regulation of nitric oxide biosynthetic process; IDA:RGD.
DR   GO; GO:0046622; P:positive regulation of organ growth; ISO:RGD.
DR   GO; GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; ISO:RGD.
DR   GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISO:RGD.
DR   GO; GO:0051247; P:positive regulation of protein metabolic process; ISO:RGD.
DR   GO; GO:0032930; P:positive regulation of superoxide anion generation; IDA:RGD.
DR   GO; GO:1904754; P:positive regulation of vascular associated smooth muscle cell migration; IDA:RGD.
DR   GO; GO:1904707; P:positive regulation of vascular associated smooth muscle cell proliferation; IDA:RGD.
DR   GO; GO:0006606; P:protein import into nucleus; IDA:RGD.
DR   GO; GO:0042981; P:regulation of apoptotic process; IDA:RGD.
DR   GO; GO:0008217; P:regulation of blood pressure; ISO:RGD.
DR   GO; GO:0051924; P:regulation of calcium ion transport; IDA:RGD.
DR   GO; GO:1903779; P:regulation of cardiac conduction; ISO:RGD.
DR   GO; GO:1901201; P:regulation of extracellular matrix assembly; ISO:RGD.
DR   GO; GO:0010468; P:regulation of gene expression; ISO:RGD.
DR   GO; GO:0002027; P:regulation of heart rate; IDA:RGD.
DR   GO; GO:0050727; P:regulation of inflammatory response; ISO:RGD.
DR   GO; GO:0048169; P:regulation of long-term neuronal synaptic plasticity; IMP:RGD.
DR   GO; GO:0014061; P:regulation of norepinephrine secretion; IMP:RGD.
DR   GO; GO:0002019; P:regulation of renal output by angiotensin; ISO:RGD.
DR   GO; GO:0001991; P:regulation of systemic arterial blood pressure by circulatory renin-angiotensin; ISO:RGD.
DR   GO; GO:0051969; P:regulation of transmission of nerve impulse; IDA:RGD.
DR   GO; GO:0001999; P:renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure; ISO:RGD.
DR   GO; GO:0003014; P:renal system process; ISO:RGD.
DR   GO; GO:0002018; P:renin-angiotensin regulation of aldosterone production; IDA:RGD.
DR   GO; GO:1990776; P:response to angiotensin; ISO:RGD.
DR   GO; GO:0009409; P:response to cold; ISO:RGD.
DR   GO; GO:0032355; P:response to estradiol; IEP:RGD.
DR   GO; GO:0009612; P:response to mechanical stimulus; IEP:RGD.
DR   GO; GO:0014873; P:response to muscle activity involved in regulation of muscle adaptation; IMP:BHF-UCL.
DR   GO; GO:0009651; P:response to salt stress; ISO:RGD.
DR   GO; GO:0051145; P:smooth muscle cell differentiation; ISO:RGD.
DR   GO; GO:0048659; P:smooth muscle cell proliferation; IDA:RGD.
DR   GO; GO:0051403; P:stress-activated MAPK cascade; IDA:RGD.
DR   GO; GO:0070471; P:uterine smooth muscle contraction; IDA:RGD.
DR   GO; GO:1990874; P:vascular associated smooth muscle cell proliferation; ISO:RGD.
DR   GO; GO:0042310; P:vasoconstriction; IDA:RGD.
DR   GO; GO:0042311; P:vasodilation; IDA:RGD.
DR   GO; GO:0030103; P:vasopressin secretion; ISO:RGD.
DR   CDD; cd02054; serpinA8_AGT; 1.
DR   Gene3D; 2.30.39.10; Alpha-1-antitrypsin, domain 1; 1.
DR   Gene3D; 3.30.497.10; Antithrombin, subunit I, domain 2; 1.
DR   InterPro; IPR000227; Angiotensinogen.
DR   InterPro; IPR033834; Angiotensinogen_serpin_dom.
DR   InterPro; IPR023796; Serpin_dom.
DR   InterPro; IPR000215; Serpin_fam.
DR   InterPro; IPR036186; Serpin_sf.
DR   InterPro; IPR042178; Serpin_sf_1.
DR   InterPro; IPR042185; Serpin_sf_2.
DR   PANTHER; PTHR11461:SF13; ANGIOTENSINOGEN; 1.
DR   PANTHER; PTHR11461; SERINE PROTEASE INHIBITOR, SERPIN; 1.
DR   Pfam; PF00079; Serpin; 1.
DR   PRINTS; PR00654; ANGIOTENSNGN.
DR   SMART; SM00093; SERPIN; 1.
DR   SUPFAM; SSF56574; Serpins; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Direct protein sequencing; Disulfide bond; Glycoprotein;
KW   Reference proteome; Secreted; Signal; Vasoactive; Vasoconstrictor.
FT   SIGNAL          1..24
FT                   /evidence="ECO:0000269|PubMed:4344907"
FT   CHAIN           25..477
FT                   /note="Angiotensinogen"
FT                   /id="PRO_0000032468"
FT   PEPTIDE         25..34
FT                   /note="Angiotensin-1"
FT                   /evidence="ECO:0000269|PubMed:4344907"
FT                   /id="PRO_0000032469"
FT   PEPTIDE         25..33
FT                   /note="Angiotensin 1-9"
FT                   /evidence="ECO:0000250|UniProtKB:P01019"
FT                   /id="PRO_0000420674"
FT   PEPTIDE         25..32
FT                   /note="Angiotensin-2"
FT                   /evidence="ECO:0000250|UniProtKB:P01019"
FT                   /id="PRO_0000032470"
FT   PEPTIDE         25..31
FT                   /note="Angiotensin 1-7"
FT                   /evidence="ECO:0000250|UniProtKB:P01019"
FT                   /id="PRO_0000420675"
FT   PEPTIDE         25..29
FT                   /note="Angiotensin 1-5"
FT                   /evidence="ECO:0000250|UniProtKB:P01019"
FT                   /id="PRO_0000420676"
FT   PEPTIDE         25..28
FT                   /note="Angiotensin 1-4"
FT                   /evidence="ECO:0000250|UniProtKB:P01019"
FT                   /id="PRO_0000420677"
FT   PEPTIDE         26..32
FT                   /note="Angiotensin-3"
FT                   /evidence="ECO:0000250|UniProtKB:P01019"
FT                   /id="PRO_0000032471"
FT   PEPTIDE         27..32
FT                   /note="Angiotensin-4"
FT                   /evidence="ECO:0000250|UniProtKB:P01019"
FT                   /id="PRO_0000420678"
FT   CARBOHYD        295
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        319
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        42..161
FT                   /evidence="ECO:0000269|PubMed:20927107"
FT   TURN            33..35
FT                   /evidence="ECO:0007829|PDB:2WXZ"
FT   HELIX           39..43
FT                   /evidence="ECO:0007829|PDB:2WXZ"
FT   HELIX           72..84
FT                   /evidence="ECO:0007829|PDB:2WXZ"
FT   HELIX           88..115
FT                   /evidence="ECO:0007829|PDB:2WXZ"
FT   STRAND          120..124
FT                   /evidence="ECO:0007829|PDB:2WXZ"
FT   HELIX           126..138
FT                   /evidence="ECO:0007829|PDB:2WXZ"
FT   HELIX           142..151
FT                   /evidence="ECO:0007829|PDB:2WXZ"
FT   HELIX           167..181
FT                   /evidence="ECO:0007829|PDB:2WXZ"
FT   STRAND          193..203
FT                   /evidence="ECO:0007829|PDB:2WXZ"
FT   HELIX           211..216
FT                   /evidence="ECO:0007829|PDB:2WXZ"
FT   TURN            217..220
FT                   /evidence="ECO:0007829|PDB:2WXZ"
FT   STRAND          224..228
FT                   /evidence="ECO:0007829|PDB:2WXZ"
FT   STRAND          231..233
FT                   /evidence="ECO:0007829|PDB:2WXZ"
FT   HELIX           235..250
FT                   /evidence="ECO:0007829|PDB:2WXZ"
FT   STRAND          267..279
FT                   /evidence="ECO:0007829|PDB:2WXZ"
FT   STRAND          282..284
FT                   /evidence="ECO:0007829|PDB:2WY1"
FT   STRAND          289..294
FT                   /evidence="ECO:0007829|PDB:2WXZ"
FT   STRAND          297..301
FT                   /evidence="ECO:0007829|PDB:2WXZ"
FT   STRAND          303..315
FT                   /evidence="ECO:0007829|PDB:2WXZ"
FT   TURN            316..319
FT                   /evidence="ECO:0007829|PDB:2WXZ"
FT   STRAND          320..340
FT                   /evidence="ECO:0007829|PDB:2WXZ"
FT   HELIX           341..343
FT                   /evidence="ECO:0007829|PDB:2WXZ"
FT   HELIX           344..351
FT                   /evidence="ECO:0007829|PDB:2WXZ"
FT   STRAND          353..355
FT                   /evidence="ECO:0007829|PDB:2WXZ"
FT   STRAND          366..373
FT                   /evidence="ECO:0007829|PDB:2WXZ"
FT   STRAND          375..382
FT                   /evidence="ECO:0007829|PDB:2WXZ"
FT   HELIX           383..389
FT                   /evidence="ECO:0007829|PDB:2WXZ"
FT   TURN            393..396
FT                   /evidence="ECO:0007829|PDB:2WXZ"
FT   HELIX           403..405
FT                   /evidence="ECO:0007829|PDB:2WXZ"
FT   STRAND          406..408
FT                   /evidence="ECO:0007829|PDB:2WXZ"
FT   STRAND          416..425
FT                   /evidence="ECO:0007829|PDB:2WXZ"
FT   STRAND          452..458
FT                   /evidence="ECO:0007829|PDB:2WXZ"
FT   TURN            459..462
FT                   /evidence="ECO:0007829|PDB:2WXZ"
FT   STRAND          463..471
FT                   /evidence="ECO:0007829|PDB:2WXZ"
SQ   SEQUENCE   477 AA;  51982 MW;  689051A5788D693D CRC64;
     MTPTGAGLKA TIFCILTWVS LTAGDRVYIH PFHLLYYSKS TCAQLENPSV ETLPEPTFEP
     VPIQAKTSPV DEKTLRDKLV LATEKLEAED RQRAAQVAMI ANFMGFRMYK MLSEARGVAS
     GAVLSPPALF GTLVSFYLGS LDPTASQLQV LLGVPVKEGD CTSRLDGHKV LTALQAVQGL
     LVTQGGSSSQ TPLLQSTVVG LFTAPGLRLK QPFVESLGPF TPAIFPRSLD LSTDPVLAAQ
     KINRFVQAVT GWKMNLPLEG VSTDSTLFFN TYVHFQGKMR GFSQLTGLHE FWVDNSTSVS
     VPMLSGTGNF QHWSDAQNNF SVTRVPLGES VTLLLIQPQC ASDLDRVEVL VFQHDFLTWI
     KNPPPRAIRL TLPQLEIRGS YNLQDLLAQA KLSTLLGAEA NLGKMGDTNP RVGEVLNSIL
     LELQAGEEEQ PTESAQQPGS PEVLDVTLSS PFLFAIYERD SGALHFLGRV DNPQNVV
//
